Tower Research Capital LLC (Trc) Teva Pharmaceutical Industries LTD Transaction History
Tower Research Capital LLC (Trc)
- $4.87 Billion
- Q4 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 739 shares of TEVA stock, worth $12,163. This represents 0.0% of its overall portfolio holdings.
Number of Shares
739
Previous 29,619
97.5%
Holding current value
$12,163
Previous $533,000
97.0%
% of portfolio
0.0%
Previous 0.01%
Shares
29 transactions
Others Institutions Holding TEVA
# of Institutions
678Shares Held
578MCall Options Held
25.5MPut Options Held
14.7M-
Black Rock Inc. New York, NY43MShares$708 Million0.02% of portfolio
-
Clal Insurance Enterprises Holdings LTD Tel Aviv, L339MShares$641 Million7.75% of portfolio
-
Ion Asset Management Ltd. George Town, Grand Cayman, E936.7MShares$603 Million48.01% of portfolio
-
Menora Mivtachim Holdings Ltd.28.4MShares$467 Million3.94% of portfolio
-
Exor Capital LLP London, X027.2MShares$448 Million17.5% of portfolio
About TEVA PHARMACEUTICAL INDUSTRIES LTD
- Ticker TEVA
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 1,110,560,000
- Market Cap $18.3B
- Description
- Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...